The global Epilepsy Drug market was valued at US$ 1839.1 million in 2023 and is anticipated to reach US$ 2031.8 million by 2030, witnessing a CAGR of 1.4% during the forecast period 2024-2030.

Epilepsy Drug Market

Epilepsy is a chronic brain disorder characterized by sudden and recurrent episodes of seizure.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Epilepsy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epilepsy Drug.

Report Scope

The Epilepsy Drug market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epilepsy Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Epilepsy Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Epilepsy Drug Market Report

Report Metric	Details
Report Name	Epilepsy Drug Market
Accounted market size in 2023	US$ 1839.1 million
Forecasted market size in 2030	US$ 2031.8 million
CAGR	1.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	First Generation Drugs Second Generation Drugs Third Generation Drugs
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Eisai, Novartis, Sanofi, Union Chimique Belge, Abbott, GlaxoSmithKline, Sunovion Pharmaceuticals, Teva Pharmaceutical, Johnson & Johnson, Abbvie, Janssen Pharmaceuticals, Cephalon
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epilepsy Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epilepsy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Epilepsy Drug Market growing?

Ans: The Epilepsy Drug Market witnessing a CAGR of 1.4% during the forecast period 2024-2030.

What is the Epilepsy Drug Market size in 2030?

Ans: The Epilepsy Drug Market size in 2030 will be US$ 2031.8 million.

Who are the main players in the Epilepsy Drug Market report?

Ans: The main players in the Epilepsy Drug Market are Pfizer, Eisai, Novartis, Sanofi, Union Chimique Belge, Abbott, GlaxoSmithKline, Sunovion Pharmaceuticals, Teva Pharmaceutical, Johnson & Johnson, Abbvie, Janssen Pharmaceuticals, Cephalon

What are the Application segmentation covered in the Epilepsy Drug Market report?

Ans: The Applications covered in the Epilepsy Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Epilepsy Drug Market report?

Ans: The Types covered in the Epilepsy Drug Market report are First Generation Drugs, Second Generation Drugs, Third Generation Drugs

1 Epilepsy Drug Market Overview

1.1 Product Overview and Scope of Epilepsy Drug

1.2 Epilepsy Drug Segment by Type

1.2.1 Global Epilepsy Drug Market Value Comparison by Type (2024-2030)

1.2.2 First Generation Drugs

1.2.3 Second Generation Drugs

1.2.4 Third Generation Drugs

1.3 Epilepsy Drug Segment by Application

1.3.1 Global Epilepsy Drug Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Epilepsy Drug Market Size Estimates and Forecasts

1.4.1 Global Epilepsy Drug Revenue 2019-2030

1.4.2 Global Epilepsy Drug Sales 2019-2030

1.4.3 Global Epilepsy Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Epilepsy Drug Market Competition by Manufacturers

2.1 Global Epilepsy Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Epilepsy Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Epilepsy Drug Average Price by Manufacturers (2019-2024)

2.4 Global Epilepsy Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Epilepsy Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Epilepsy Drug, Product Type & Application

2.7 Epilepsy Drug Market Competitive Situation and Trends

2.7.1 Epilepsy Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Epilepsy Drug Players Market Share by Revenue

2.7.3 Global Epilepsy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Epilepsy Drug Retrospective Market Scenario by Region

3.1 Global Epilepsy Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Epilepsy Drug Global Epilepsy Drug Sales by Region: 2019-2030

3.2.1 Global Epilepsy Drug Sales by Region: 2019-2024

3.2.2 Global Epilepsy Drug Sales by Region: 2025-2030

3.3 Global Epilepsy Drug Global Epilepsy Drug Revenue by Region: 2019-2030

3.3.1 Global Epilepsy Drug Revenue by Region: 2019-2024

3.3.2 Global Epilepsy Drug Revenue by Region: 2025-2030

3.4 North America Epilepsy Drug Market Facts & Figures by Country

3.4.1 North America Epilepsy Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Epilepsy Drug Sales by Country (2019-2030)

3.4.3 North America Epilepsy Drug Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Epilepsy Drug Market Facts & Figures by Country

3.5.1 Europe Epilepsy Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Epilepsy Drug Sales by Country (2019-2030)

3.5.3 Europe Epilepsy Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Epilepsy Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Epilepsy Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Epilepsy Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Epilepsy Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Epilepsy Drug Market Facts & Figures by Country

3.7.1 Latin America Epilepsy Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Epilepsy Drug Sales by Country (2019-2030)

3.7.3 Latin America Epilepsy Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Epilepsy Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Epilepsy Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Epilepsy Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Epilepsy Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Epilepsy Drug Sales by Type (2019-2030)

4.1.1 Global Epilepsy Drug Sales by Type (2019-2024)

4.1.2 Global Epilepsy Drug Sales by Type (2025-2030)

4.1.3 Global Epilepsy Drug Sales Market Share by Type (2019-2030)

4.2 Global Epilepsy Drug Revenue by Type (2019-2030)

4.2.1 Global Epilepsy Drug Revenue by Type (2019-2024)

4.2.2 Global Epilepsy Drug Revenue by Type (2025-2030)

4.2.3 Global Epilepsy Drug Revenue Market Share by Type (2019-2030)

4.3 Global Epilepsy Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Epilepsy Drug Sales by Application (2019-2030)

5.1.1 Global Epilepsy Drug Sales by Application (2019-2024)

5.1.2 Global Epilepsy Drug Sales by Application (2025-2030)

5.1.3 Global Epilepsy Drug Sales Market Share by Application (2019-2030)

5.2 Global Epilepsy Drug Revenue by Application (2019-2030)

5.2.1 Global Epilepsy Drug Revenue by Application (2019-2024)

5.2.2 Global Epilepsy Drug Revenue by Application (2025-2030)

5.2.3 Global Epilepsy Drug Revenue Market Share by Application (2019-2030)

5.3 Global Epilepsy Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Epilepsy Drug Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Eisai

6.2.1 Eisai Corporation Information

6.2.2 Eisai Description and Business Overview

6.2.3 Eisai Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Eisai Epilepsy Drug Product Portfolio

6.2.5 Eisai Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Corporation Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Novartis Epilepsy Drug Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Sanofi

6.4.1 Sanofi Corporation Information

6.4.2 Sanofi Description and Business Overview

6.4.3 Sanofi Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sanofi Epilepsy Drug Product Portfolio

6.4.5 Sanofi Recent Developments/Updates

6.5 Union Chimique Belge

6.5.1 Union Chimique Belge Corporation Information

6.5.2 Union Chimique Belge Description and Business Overview

6.5.3 Union Chimique Belge Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Union Chimique Belge Epilepsy Drug Product Portfolio

6.5.5 Union Chimique Belge Recent Developments/Updates

6.6 Abbott

6.6.1 Abbott Corporation Information

6.6.2 Abbott Description and Business Overview

6.6.3 Abbott Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Abbott Epilepsy Drug Product Portfolio

6.6.5 Abbott Recent Developments/Updates

6.7 GlaxoSmithKline

6.6.1 GlaxoSmithKline Corporation Information

6.6.2 GlaxoSmithKline Description and Business Overview

6.6.3 GlaxoSmithKline Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GlaxoSmithKline Epilepsy Drug Product Portfolio

6.7.5 GlaxoSmithKline Recent Developments/Updates

6.8 Sunovion Pharmaceuticals

6.8.1 Sunovion Pharmaceuticals Corporation Information

6.8.2 Sunovion Pharmaceuticals Description and Business Overview

6.8.3 Sunovion Pharmaceuticals Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Sunovion Pharmaceuticals Epilepsy Drug Product Portfolio

6.8.5 Sunovion Pharmaceuticals Recent Developments/Updates

6.9 Teva Pharmaceutical

6.9.1 Teva Pharmaceutical Corporation Information

6.9.2 Teva Pharmaceutical Description and Business Overview

6.9.3 Teva Pharmaceutical Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Teva Pharmaceutical Epilepsy Drug Product Portfolio

6.9.5 Teva Pharmaceutical Recent Developments/Updates

6.10 Johnson & Johnson

6.10.1 Johnson & Johnson Corporation Information

6.10.2 Johnson & Johnson Description and Business Overview

6.10.3 Johnson & Johnson Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Johnson & Johnson Epilepsy Drug Product Portfolio

6.10.5 Johnson & Johnson Recent Developments/Updates

6.11 Abbvie

6.11.1 Abbvie Corporation Information

6.11.2 Abbvie Epilepsy Drug Description and Business Overview

6.11.3 Abbvie Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Abbvie Epilepsy Drug Product Portfolio

6.11.5 Abbvie Recent Developments/Updates

6.12 Janssen Pharmaceuticals

6.12.1 Janssen Pharmaceuticals Corporation Information

6.12.2 Janssen Pharmaceuticals Epilepsy Drug Description and Business Overview

6.12.3 Janssen Pharmaceuticals Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Janssen Pharmaceuticals Epilepsy Drug Product Portfolio

6.12.5 Janssen Pharmaceuticals Recent Developments/Updates

6.13 Cephalon

6.13.1 Cephalon Corporation Information

6.13.2 Cephalon Epilepsy Drug Description and Business Overview

6.13.3 Cephalon Epilepsy Drug Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Cephalon Epilepsy Drug Product Portfolio

6.13.5 Cephalon Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Epilepsy Drug Industry Chain Analysis

7.2 Epilepsy Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Epilepsy Drug Production Mode & Process

7.4 Epilepsy Drug Sales and Marketing

7.4.1 Epilepsy Drug Sales Channels

7.4.2 Epilepsy Drug Distributors

7.5 Epilepsy Drug Customers

8 Epilepsy Drug Market Dynamics

8.1 Epilepsy Drug Industry Trends

8.2 Epilepsy Drug Market Drivers

8.3 Epilepsy Drug Market Challenges

8.4 Epilepsy Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sunovion Pharmaceuticals

Teva Pharmaceutical

Johnson & Johnson

AbbVie

Janssen Pharmaceuticals

Cephalon

List of Tables

Table 1. Global Epilepsy Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Epilepsy Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Epilepsy Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Epilepsy Drug Sales (Units) of Key Manufacturers (2019-2024)

Table 5. Global Epilepsy Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Epilepsy Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Epilepsy Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Epilepsy Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Epilepsy Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Epilepsy Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Epilepsy Drug, Product Type & Application

Table 12. Global Key Manufacturers of Epilepsy Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Epilepsy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Epilepsy Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Epilepsy Drug Sales by Region (2019-2024) & (Units)

Table 18. Global Epilepsy Drug Sales Market Share by Region (2019-2024)

Table 19. Global Epilepsy Drug Sales by Region (2025-2030) & (Units)

Table 20. Global Epilepsy Drug Sales Market Share by Region (2025-2030)

Table 21. Global Epilepsy Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Epilepsy Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Epilepsy Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Epilepsy Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Epilepsy Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Epilepsy Drug Sales by Country (2019-2024) & (Units)

Table 27. North America Epilepsy Drug Sales by Country (2025-2030) & (Units)

Table 28. North America Epilepsy Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Epilepsy Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Epilepsy Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Epilepsy Drug Sales by Country (2019-2024) & (Units)

Table 32. Europe Epilepsy Drug Sales by Country (2025-2030) & (Units)

Table 33. Europe Epilepsy Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Epilepsy Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Epilepsy Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Epilepsy Drug Sales by Region (2019-2024) & (Units)

Table 37. Asia Pacific Epilepsy Drug Sales by Region (2025-2030) & (Units)

Table 38. Asia Pacific Epilepsy Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Epilepsy Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Epilepsy Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Epilepsy Drug Sales by Country (2019-2024) & (Units)

Table 42. Latin America Epilepsy Drug Sales by Country (2025-2030) & (Units)

Table 43. Latin America Epilepsy Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Epilepsy Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Epilepsy Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Epilepsy Drug Sales by Country (2019-2024) & (Units)

Table 47. Middle East & Africa Epilepsy Drug Sales by Country (2025-2030) & (Units)

Table 48. Middle East & Africa Epilepsy Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Epilepsy Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Epilepsy Drug Sales (Units) by Type (2019-2024)

Table 51. Global Epilepsy Drug Sales (Units) by Type (2025-2030)

Table 52. Global Epilepsy Drug Sales Market Share by Type (2019-2024)

Table 53. Global Epilepsy Drug Sales Market Share by Type (2025-2030)

Table 54. Global Epilepsy Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Epilepsy Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Epilepsy Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Epilepsy Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Epilepsy Drug Price (USD/Unit) by Type (2019-2024)

Table 59. Global Epilepsy Drug Price (USD/Unit) by Type (2025-2030)

Table 60. Global Epilepsy Drug Sales (Units) by Application (2019-2024)

Table 61. Global Epilepsy Drug Sales (Units) by Application (2025-2030)

Table 62. Global Epilepsy Drug Sales Market Share by Application (2019-2024)

Table 63. Global Epilepsy Drug Sales Market Share by Application (2025-2030)

Table 64. Global Epilepsy Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Epilepsy Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Epilepsy Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Epilepsy Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Epilepsy Drug Price (USD/Unit) by Application (2019-2024)

Table 69. Global Epilepsy Drug Price (USD/Unit) by Application (2025-2030)

Table 70. Pfizer Corporation Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer Epilepsy Drug Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Eisai Corporation Information

Table 76. Eisai Description and Business Overview

Table 77. Eisai Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Eisai Epilepsy Drug Product

Table 79. Eisai Recent Developments/Updates

Table 80. Novartis Corporation Information

Table 81. Novartis Description and Business Overview

Table 82. Novartis Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Novartis Epilepsy Drug Product

Table 84. Novartis Recent Developments/Updates

Table 85. Sanofi Corporation Information

Table 86. Sanofi Description and Business Overview

Table 87. Sanofi Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Sanofi Epilepsy Drug Product

Table 89. Sanofi Recent Developments/Updates

Table 90. Union Chimique Belge Corporation Information

Table 91. Union Chimique Belge Description and Business Overview

Table 92. Union Chimique Belge Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Union Chimique Belge Epilepsy Drug Product

Table 94. Union Chimique Belge Recent Developments/Updates

Table 95. Abbott Corporation Information

Table 96. Abbott Description and Business Overview

Table 97. Abbott Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Abbott Epilepsy Drug Product

Table 99. Abbott Recent Developments/Updates

Table 100. GlaxoSmithKline Corporation Information

Table 101. GlaxoSmithKline Description and Business Overview

Table 102. GlaxoSmithKline Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. GlaxoSmithKline Epilepsy Drug Product

Table 104. GlaxoSmithKline Recent Developments/Updates

Table 105. Sunovion Pharmaceuticals Corporation Information

Table 106. Sunovion Pharmaceuticals Description and Business Overview

Table 107. Sunovion Pharmaceuticals Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Sunovion Pharmaceuticals Epilepsy Drug Product

Table 109. Sunovion Pharmaceuticals Recent Developments/Updates

Table 110. Teva Pharmaceutical Corporation Information

Table 111. Teva Pharmaceutical Description and Business Overview

Table 112. Teva Pharmaceutical Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Teva Pharmaceutical Epilepsy Drug Product

Table 114. Teva Pharmaceutical Recent Developments/Updates

Table 115. Johnson & Johnson Corporation Information

Table 116. Johnson & Johnson Description and Business Overview

Table 117. Johnson & Johnson Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Johnson & Johnson Epilepsy Drug Product

Table 119. Johnson & Johnson Recent Developments/Updates

Table 120. Abbvie Corporation Information

Table 121. Abbvie Description and Business Overview

Table 122. Abbvie Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Abbvie Epilepsy Drug Product

Table 124. Abbvie Recent Developments/Updates

Table 125. Janssen Pharmaceuticals Corporation Information

Table 126. Janssen Pharmaceuticals Description and Business Overview

Table 127. Janssen Pharmaceuticals Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Janssen Pharmaceuticals Epilepsy Drug Product

Table 129. Janssen Pharmaceuticals Recent Developments/Updates

Table 130. Cephalon Corporation Information

Table 131. Cephalon Description and Business Overview

Table 132. Cephalon Epilepsy Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Cephalon Epilepsy Drug Product

Table 134. Cephalon Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Epilepsy Drug Distributors List

Table 138. Epilepsy Drug Customers List

Table 139. Epilepsy Drug Market Trends

Table 140. Epilepsy Drug Market Drivers

Table 141. Epilepsy Drug Market Challenges

Table 142. Epilepsy Drug Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Epilepsy Drug

Figure 2. Global Epilepsy Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Epilepsy Drug Market Share by Type in 2023 & 2030

Figure 4. First Generation Drugs Product Picture

Figure 5. Second Generation Drugs Product Picture

Figure 6. Third Generation Drugs Product Picture

Figure 7. Global Epilepsy Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Epilepsy Drug Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Others

Figure 12. Global Epilepsy Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Epilepsy Drug Market Size (2019-2030) & (US$ Million)

Figure 14. Global Epilepsy Drug Sales (2019-2030) & (Units)

Figure 15. Global Epilepsy Drug Average Price (USD/Unit) & (2019-2030)

Figure 16. Epilepsy Drug Report Years Considered

Figure 17. Epilepsy Drug Sales Share by Manufacturers in 2023

Figure 18. Global Epilepsy Drug Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Epilepsy Drug Players: Market Share by Revenue in 2023

Figure 20. Epilepsy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Epilepsy Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Epilepsy Drug Sales Market Share by Country (2019-2030)

Figure 23. North America Epilepsy Drug Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Epilepsy Drug Sales Market Share by Country (2019-2030)

Figure 27. Europe Epilepsy Drug Revenue Market Share by Country (2019-2030)

Figure 28. Germany Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Epilepsy Drug Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Epilepsy Drug Revenue Market Share by Region (2019-2030)

Figure 35. China Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Epilepsy Drug Sales Market Share by Country (2019-2030)

Figure 46. Latin America Epilepsy Drug Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Epilepsy Drug Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Epilepsy Drug Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. U.A.E Epilepsy Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Epilepsy Drug by Type (2019-2030)

Figure 56. Global Revenue Market Share of Epilepsy Drug by Type (2019-2030)

Figure 57. Global Epilepsy Drug Price (USD/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Epilepsy Drug by Application (2019-2030)

Figure 59. Global Revenue Market Share of Epilepsy Drug by Application (2019-2030)

Figure 60. Global Epilepsy Drug Price (USD/Unit) by Application (2019-2030)

Figure 61. Epilepsy Drug Value Chain

Figure 62. Epilepsy Drug Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Cerebral Palsy Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36K2790

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Chorea Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-22U5801

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Autism Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29P12566

Mon Mar 25 00:00:00 UTC 2024

Add to Cart

Spinal Cord Stimulation Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-11Z11048

Thu Mar 21 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions